Please note, this OEL/ADE monograph also applies to Oxantel pamoate/oxantel embonate (CAS RN 68813-55-8) and Oxantel tartrate (CAS RN 71865-30-0). Oxantel pamoate is an antiparastic used as a dewormer in cats and dogs. It is not used in food producing animals. An approved indication in humans could not be found, however, it being extensively investigated for the treatment of several indications. Oxantel pamoate belongs to a class of drugs called tetrahydropyrimidines that also include pyrantel and morantel. The tetrahydropyrimidines exert their effects on parasites by inducing marked activation of nicotinic receptors producing spastic paralysis.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Oxantel, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.